WEST BRIDGEWATER, Mass.--(BUSINESS WIRE)--GI Windows, Inc., a clinical-stage medical device company, today announced the presentation of six-month results of the first-ever clinical study evaluating ...

GI Windows, Inc., a clinical-stage medical device company, today announced the presentation of six-month results of the first-ever clinical study evaluating the endoscopic creation of a dual-path ...

West Bridgewater, Mass.-based GI Windows was named Emerging MedTech Company of the Year by the New England Venture Capital Association, according to a Dec. 8 press release. GI Windows is a ...

GI Windows will debut its Incision-less Anastomosis System at Digestive Disease Week 2016, which takes place from May 21 to 24 in San Diego. 1. The Incision-less Anastomosis System facilitates a ...

GI Windows Corp is the global leader in magnetic anastomosis and less invasive delivery of self-forming magnets. The company is a clinical-stage medical device company dedicated to developing the ...

WESTWOOD, MA, UNITED STATES, June 16, 2025 /EINPresswire / -- GI Windows Surgical, a leader in next-generation medical devices, today announced it has received U.S. Food and Drug Administration (FDA) ...

WEST BRIDGEWATER, Mass., Aug. 19, 2020 /PRNewswire/ -- GI Windows Medical Corp, a clinical-stage, privately-held medical device company, announced a $16.4 million Series A-1 financing. The financing ...

GI Windows Corp. scooped up $16.4 million in a series A-1 financing that included investment from Johnson & Johnson Innovation – JJDC Inc., Sonder Capital, GT Healthcare, JC Investco and an unnamed ...

BOSTON, Dec. 8, 2020 /PRNewswire/ -- Last week, in homes all over New England, the New England Venture Capital Association (NEVCA) honored the winners of its eighth annual NEVY Awards, recognizing and ...

WESTWOOD, MA, UNITED STATES, November 20, 2024 / EINPresswire.com / -- GI Windows Surgical, Westwood, MA, announced today that it has secured $37 million in additional funding to support the continued ...

GI Windows Corp. scooped up $16.4 million in a series A-1 financing that included investment from Johnson & Johnson Innovation – JJDC Inc., Sonder Capital, GT Healthcare, JC Investco and an unnamed ...